MDJunction - People Helping People
 
Ask a Question
07/10/2009 05:40 AM

RA drugs and cancer..

kvnj
kvnj  
Posts: 3914
Group Leader

FDA reviewing arthritis drugs for cancer link

Concerns raised about cancers connected to Humira, Remicade and Enbrel

Federal regulators are investigating whether a group of best-selling arthritis drugs made by Abbott Laboratories, Schering-Plough Corp. and other companies heighten the risk of cancer in youngsters.

The Food and Drug Administration said Wednesday it has received 30 reports of children and young adults developing cancer while taking the drugs over the last 10 years. Roughly half the cases were lymphomas, a type of immune-system cancer. Others reported were leukemia, melanoma and cancers of various organs.

The drugs under review include Abbott Labs' Humira, Schering-Plough's Remicade, and Enbrel, which is marketed by Amgen Inc. and Wyeth. They are prescribed to children with arthritis to block a chemical that causes inflammation. The drugs also are used to treat children with the intestinal disorder Crohn's disease.

The products, known as tumor necrosis factor blockers, are key revenue drivers for the companies. Abbott's Humira was the company's best-selling product last year with over $3 billion in sales. Remicade also topped Schering-Plough's portfolio with sales of $1.65 billion.

The safety of Humira was reviewed in February when the FDA first cleared it for use in juvenile arthritis, Abbott said in a statement. The company has not recorded any instances of lymphoma in children.

Representatives from the other companies did not immediately return calls for comment Wednesday morning.

The FDA said the drugs' labeling already warns of a potential association with cancer, but the agency's investigation will focus on risks to younger patients.

The statement posted to the FDA's Web site said it will take long-term studies to definitively assess the drugs' safety risks since cancers take years to develop.

Belgian drug maker UBC is conducting a long-term study of risks, including cancer, with its drug Cimizia, which is part of the medication class. But the FDA said that study won't be complete until 2019.

The agency has asked drug makers to provide all information about children who developed cancer while taking the medications. Regulators will report the findings of their review by November.

Doctors should consider the risks of cancer when considering prescribing the drugs for youngsters, the FDA said.

Shares of Abbott Laboratories fell 2 cents to $55.71 in midday trading, while Schering-Plough rose 14 cents to $20.64. Amgen shares rose 12 cents to $44.27, while Wyeth fell 13 cents to $44.09.

******************************************************

PLEASE NOTE: I hate to post negative things because people automatically become fearful , but this is very important to everyone. Keep in mind, just because there's a chance of getting cancer it doesnt mean that you will!!! You have to weigh the risks against the benefits as far as quality of life issues.

Reply

07/10/2009 06:04 AM
Cyrusray
 
Posts: 746
Member

Thanks Karen......I believe in keeping my eyes OPEN also. Sticking

your head in the sand gets you nowhere.


07/10/2009 06:07 AM
gettingoldsucks
gettingoldsucks  
Posts: 3432
Senior Member

Lucky us. There is not a safe drug out there and the one that is the safest (VIC) as far as I'm concerned is the one they want to take from us.
Reply

Share this discussion with your friends:


Disclaimer: The information provided in MDJunction is not a replacement for medical diagnosis, treatment, or professional medical advice.
In case of EMERGENCY call 911 or 1.800.273.TALK (8255) to the National Suicide Prevention Lifeline. Read more.
Contact Us | About Us
Copyright (c) 2006-2014 MDJunction.com All Rights Reserved